Howard J. Lim

4.9k total citations
184 papers, 2.3k citations indexed

About

Howard J. Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Howard J. Lim has authored 184 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 68 papers in Pulmonary and Respiratory Medicine and 50 papers in Cancer Research. Recurrent topics in Howard J. Lim's work include Colorectal Cancer Treatments and Studies (56 papers), Cancer Genomics and Diagnostics (45 papers) and Gastric Cancer Management and Outcomes (30 papers). Howard J. Lim is often cited by papers focused on Colorectal Cancer Treatments and Studies (56 papers), Cancer Genomics and Diagnostics (45 papers) and Gastric Cancer Management and Outcomes (30 papers). Howard J. Lim collaborates with scholars based in Canada, United States and Japan. Howard J. Lim's co-authors include Daniel J. Renouf, Hagen F. Kennecke, Winson Y. Cheung, Sharlene Gill, Marcel B. Bally, Renata D’Alpino Peixoto, Caroline Speers, David F. Schaeffer, Thomas D. Madden and Dana Masin and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Howard J. Lim

162 papers receiving 2.3k citations

Peers

Countries citing papers authored by Howard J. Lim

Since Specialization

Citations

This map shows the geographic impact of Howard J. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard J. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard J. Lim more than expected).

Fields of papers citing papers by Howard J. Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard J. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard J. Lim. The network helps show where Howard J. Lim may publish in the future.

Co-authorship network of co-authors of Howard J. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Howard J. Lim. A scholar is included among the top collaborators of Howard J. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard J. Lim. Howard J. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated CA19-9 in IgG4-related disease 2025 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·(unknown), André Mattman, (unknown), Anthony K.-C. So, Howard J. Lim, (unknown), (unknown), David F. Schaeffer, Eric Lam, Jennifer J. Telford, Luke Y. C. Chen, Mollie N. Carruthers	0
2	Toxicological assessment of cigarette filter-derived microplastics in Daphnia magna 2025 ·Journal of Hazardous Materials ·(unknown), (unknown), Howard J. Lim, Seon-Yong Chung, Young Jun Kim, (unknown), (unknown), (unknown), (unknown)	0
3	Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma 2024 ·Genes Chromosomes and Cancer ·Veronika Csizmók, Cameron J. Grisdale, Laura Williamson, Howard J. Lim, Lawrence Lee, Daniel J. Renouf, Steven J.M. Jones, Marco A. Marra, Janessa Laskin, Alannah Smrke	3
4	Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors 2024 ·Cancer Research Communications ·(unknown), (unknown), Emma Titmuss, Robert J. Vanner, David F. Schaeffer, Aly Karsan, Howard J. Lim, Cheryl Ho, Sharlene Gill, Stephen Yip, Stephen Chia, Hagen F. Kennecke, Derek J. Jonker, Eric X. Chen, Daniel J. Renouf, Chris J. O’Callaghan, Jonathan M. Loree	2
5	Predictors of short-term death and long-term survival in advanced hepatocellular carcinoma (HCC) treated with contemporary tyrosine kinase inhibitors (TKI) or immunotherapy: A multicenter analysis from the HCC-CHORD consortium. 2024 ·Journal of Clinical Oncology ·(unknown), M. E. Freeman, (unknown), (unknown), Ravi Ramjeesingh, (unknown), (unknown), (unknown), Jessica Li, (unknown), Howard J. Lim, Jennifer J. Knox, Vallerie Gordon, Winson Y. Cheung, Vincent C. Tam, Brandon M. Meyers	1
6	Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma 2024 ·Current Oncology ·Christine Brezden‐Masley, Pierre Fiset, Carol C. Cheung, Thomas Arnason, (unknown), (unknown), (unknown), Diana Beşliu-Ionescu, Howard J. Lim, Brandon S. Sheffield, (unknown), Catherine Streutker	0
7	Best Practices for Managing Patients with Unresectable Metastatic Gastric and Gastroesophageal Junction Cancer in Canada 2024 ·Current Oncology ·Stephanie Snow, (unknown), Howard J. Lim, Mustapha Tehfé, Christine Brezden‐Masley	1
8	“I Just Assumed This Was Already Being Done”: Canadian Patient Preferences for Enhanced Data Sharing for Precision Oncology 2024 ·JCO Precision Oncology ·Samantha Pollard, (unknown), (unknown), Deirdre Weymann, Emanuel Krebs, Cheryl Ho, Howard J. Lim, Steven J.M. Jones, Yvonne Bombard, Timothy P. Hanna, (unknown), Holly Longstaff, Robert Cook‐Deegan, Tania Bubela, Dean A. Regier	1
9	Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel 2024 ·Journal of Vascular and Interventional Radiology ·(unknown), Nadine Abi‐Jaoudeh, Howard J. Lim, Katerina Malagari, Benjamin Spieler, Masatoshi Kudo, Richard S. Finn, Riccardo Lencioni, Sarah B. White, Nima Kokabi, D. Rohan Jeyarajah, Prosanto Chaudhury, David Liu	1
10	A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada 2023 ·Current Oncology ·Ravi Ramjeesingh, Prosanto Chaudhury, Vincent C. Tam, David Roberge, Howard J. Lim, Jennifer J. Knox, Jamil Asselah, Sarah Doucette, (unknown), Rachel Goodwin	8
11	Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022 2023 ·Current Oncology ·Sharlene Gill, Shahid Ahmed, (unknown), Scott Berry, Howard J. Lim, P. Terry Phang, Ankur Sharma, (unknown), Karamjit Gill, Mussawar Iqbal, Keith Tankel, (unknown), (unknown), (unknown), (unknown), (unknown), Karen Mulder	1
12	An Evaluation of the Quality of COVID-19 Internet Resources for Cancer Patients 2022 ·Journal of Cancer Education ·(unknown), Christine Simmons, Howard J. Lim, Paris‐Ann Ingledew	6
13	Defining a Core Data Set for the Economic Evaluation of Precision Oncology 2022 ·Value in Health ·Samantha Pollard, Deirdre Weymann, (unknown), (unknown), Sarah Wordsworth, James Buchanan, Timothy P. Hanna, Cheryl Ho, Howard J. Lim, Paula Lorgelly, Adam Raymakers, Christopher McCabe, Dean A. Regier	11
14	Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis 2020 ·Clinical Cancer Research ·Jenny E. Chu, Benny Johnson, (unknown), Van K. Morris, Kanwal Raghav, (unknown), Howard J. Lim, Daniel J. Renouf, Sharlene Gill, Robert Wolber, Aly Karsan, Scott Kopetz, David F. Schaeffer, Jonathan M. Loree	31
15	Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases 2020 ·Canadian Journal of Gastroenterology and Hepatology ·Erica S. Tsang, Jonathan M. Loree, Janine M. Davies, Sharlene Gill, David Liu, Stephen Ho, Daniel J. Renouf, Howard J. Lim, Hagen F. Kennecke	10
16	NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option 2019 ·Annals of Oncology ·Benjamin A. Weinberg, Daniel J. Renouf, Howard J. Lim, Christoph Heining, Richard F. Schlenk, Martin Jones, (unknown), A. Cseh, Flavio Solca, Janessa Laskin	3
17	Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer 2015 ·Clinical Colorectal Cancer ·Jenny J. Ko, Hagen F. Kennecke, Howard J. Lim, Daniel J. Renouf, Sharlene Gill, Ryan Woods, Caroline Speers, Winson Y. Cheung	42
18	Perioperative Chemotherapy for Gastroesophageal Cancer in British Columbia: A Multicentre Experience 2014 ·Current Oncology ·Renata D’Alpino Peixoto, Winson Y. Cheung, Howard J. Lim	2
19	Absence of MMP2 Expression Correlates with Poor Clinical Outcomes in Rectal Cancer, and Is Distinct from MMP1-Related Outcomes in Colon Cancer 2011 ·Clinical Cancer Research ·John C.T. Wong, Simon K. Chan, David F. Schaeffer, Xavier Sagaert, Howard J. Lim, Hagen F. Kennecke, David Owen, Kwang Wook Suh, Young‐Bae Kim, Isabella T. Tai	31
20	A Japanese Agenda for Management Development. 1982 ·Training and development journal ·Howard J. Lim	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact